QNTM Stock: Quantum BioPharma Ltd. Stock Price, Analysis & Insights
Get live qntm stock price $10.08, comprehensive Quantum BioPharma Ltd. stock analysis, charts, news, and expert forecast. Real-time qntm stock data and investment insights.
Loading chart...
Company Overview
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
Company Information
- CEO
- Zeeshan Saeed
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- N/A
Contact Information
- Address
- 55 University Ave.
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.75) may provide portfolio stability
Business Model & Strategy
Quantum BioPharma Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Zeeshan Saeed, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Quantum BioPharma Ltd. competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 38.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Quantum BioPharma Ltd. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Quantum BioPharma Ltd. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Quantum BioPharma Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Quantum BioPharma Ltd.
- ⚠Investors should consider how Quantum BioPharma Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
38.48M
P/E Ratio
-1.06
Beta
0.75
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 38.48M market capitalization
- Trading Volume: 666.45K shares traded today
- Price Range: 52-week range of $2.70 - $38.25
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (QNTM) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 38.48M, the company represents a significant player in its market. The stock is currently trading at $10.08 with a positivedaily change of 25.37%.
The company's substantial employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.06, beta of 0.75, and 52-week price range from $2.70 to $38.25when evaluating investment opportunities.
Why Invest in Quantum BioPharma Ltd.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Zeeshan Saeed
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.